20
Cat No. | Product Name | Synonyms | Targets |
---|---|---|---|
T9210 | CD73-IN-4 | CD73 | |
CD73-IN-4 is a potent and selective methylenephosphonic acid CD73 inhibitor | |||
T8875 | CD73-IN-3 | EX-A4254,LY-3475070 | CD73 |
CD73-IN-3 (LY-3475070) is a potent and selective CD73 inhibitor with an IC50 of 28 nM, and its use alone or in combination with pembrolizumab is currently being tested in patients with advanced cancer. | |||
T40033 | CD73-IN-5 | CD73-IN-5 | |
CD73-IN-5 is a highly potent and selective small molecule inhibitor of CD73, demonstrating non-nucleotide characteristics. It exerts its inhibitory effects with a remarkable IC50 value of 19 nM. | |||
T10721 | CD73-IN-1 | CD73 | |
CD73-IN-1 is a CD73 inhibitor with anticancer activity. | |||
T61118 | CD73-IN-12 | ||
CD73-IN-12 is a highly effective CD73 inhibitor that displays strong potential in tumor suppression. CD73, an enzyme intricately linked to tumor development, angiogenesis, and metastasis, is significantly inhibited by CD... | |||
T60779 | CD73-IN-13 | ||
CD73-IN-13 is able to be used in a medicament preparing for tumor-related diseases. CD73-IN-13 is a potent inhibitor of CD73 which is closely associated with tumor growth, angiogenesis and metastasis [1]. | |||
T61053 | CD73-IN-11 | ||
CD73-IN-11 is able to used for tumor-related diseases medicament preparing. CD73-IN-11 is an effective CD73 inhibitor. CD73 can catalyze the production of adenosine from extracellular 5'-phosphate adenosine (5'-AMP) whic... | |||
T63128 | CD73-IN-2 | ||
CD73-IN-2 is a potent inhibitor of CD73 (IC50: 0.09 nM). | |||
T61691 | CD73-IN-6 | ||
CD73-IN-6, serves as a potent inhibitor of CD73. This compound finds utility in cancer research [1]. | |||
T61090 | CD73-IN-8 | ||
CD73-IN-8, a potent CD73 inhibitor, prevents the catalytic activity of CD73, an enzyme responsible for converting extracellular 5'-phosphate adenosine (5'-AMP) to adenosine. Adenosine, once produced, can induce immunosup... | |||
T61000 | CD73-IN-10 | ||
CD73-IN-10 can be used in preparing tumor-related diseases medicament. CD73-IN-10 is a potent CD73 inhibitor that can catalyze the adenosine production from extracellular 5'-phosphate adenosine (5'-AMP). Adenosine induce... | |||
T60844 | CD73-IN-9 | ||
CD73-IN-9 is a potent CD73 inhibitor that be used in preparing the tumor-related diseases medicament. CD73 can catalyze the adenosine production from extracellular 5'-phosphate adenosine (5'-AMP). The adenosine can induc... | |||
T60599 | CD73-IN-7 | ||
CD73-IN-7 is a potent CD73 inhibitor that can be used for preparing a medicament for tumor-related diseases. CD73 can catalyze the production of adenosine from extracellular 5'-phosphate adenosine (5'-AMP) which can indu... | |||
T10216 | AB-680 | CD73 | |
AB-680 is a highly potent, reversible, and selective inhibitor of CD73 (an ectonucleotidase, Ki: 4.9 pM for hCD73) with anti-tumor activity, displays >10,000-fold selectivity over related ectonucleotidases CD39. | |||
T76735 | Mupadolimab | CPI-006 | CD73 |
Mupadolimab (CPI-006) is a humanized FC-γR binding deficient IgG1 anti-CD73 antibody with potential anticancer activity and activation of CD73POS B cells. | |||
T12569L | PSB-12379 ditriethylamine salt | CD73 | |
PSB-12379 ditriethylamine salt, a nucleotide analogue, is a potent Ecto-5'-Nucleotidase (CD73) inhibitor with Kis of 9.03 nM (rat) and 2.21 nM (human). | |||
T22392 | OP-5244 | Others | |
OP-5244 has comparable potency to bisphosphonic acid series and targets CD73. | |||
T12007 | MethADP sodium salt | Others | |
MethADP is a specific CD73 inhibitor. | |||
T12008 | MethADP | Adenosine 5'-(α,β-methylene)diphosphate | Others |
MethADP is a specific inhibitor of CD73. | |||
T12569 | PSB-12379 | Others | |
PSB-12379 is a potent inhibitor of Ecto-5'-Nucleotidase (CD73)(Kis of 9.03 nM (rat) and 2.21 nM (human)). |